July 27, 2022—CellaVision announced today at the AACC meeting the launch of Diff-Line by CellaVision, a workflow solution for low-volume hematology laboratories.
Diff-Line by CellaVision consists of three instruments for smearing, staining, and analyzing peripheral blood smears: CellaVision DC-1 (launched in 2019, FDA cleared in 2020), RAL SmearBox, and RAL StainBox.
The DC-1 is a single-slide analyzer that automates and digitizes the analysis of peripheral blood smears. It has an automated microscope, a digital camera, and a computer system that uses artificial intelligence to locate, digitally capture, and preclassify cells from stained blood smears. The preclassified cells are presented on a computer screen for review and verification.
The RAL SmearBox produces peripheral blood smears. The automated instrument uses a patented consumable to produce smears directly from a closed whole sample tube. CellaVision introduced the RAL SmearBox at the AACC meeting.
The RAL StainBox is a semiautomated instrument that uses the bath method and guides the laboratory through a step-by-step staining process. It uses MCDh methanol-free stains to ensure high stain quality and reproducibility while reducing exposure to toxic chemicals.
Diff-Line was available on the European market beginning in July, and CellaVision says it will be rolled out in additional markets this year.